HASHEM EL-SERAG to Gastroesophageal Reflux
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Gastroesophageal Reflux.
Connection Strength
10.809
-
Prevalence of Barrett's esophagus and performance of societal?screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021 02; 93(2):409-419.e1.
Score: 0.516
-
Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):175-82.e1-3.
Score: 0.362
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
Score: 0.351
-
Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):280-6.
Score: 0.341
-
Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. JAMA Intern Med. 2014 Mar; 174(3):462-5.
Score: 0.333
-
A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
Score: 0.329
-
Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil. 2014 Mar; 26(3):346-52.
Score: 0.328
-
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun; 63(6):871-80.
Score: 0.319
-
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
Score: 0.313
-
Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011 Sep; 34(6):618-27.
Score: 0.278
-
Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther. 2011 Apr; 33(7):829-36.
Score: 0.270
-
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010 Sep; 32(6):720-37.
Score: 0.261
-
Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010 Apr; 125(4):e925-30.
Score: 0.254
-
The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep; 104(9):2161-7.
Score: 0.241
-
Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009 Mar 01; 29(5):470-80.
Score: 0.231
-
Epidemiology of non-erosive reflux disease. Digestion. 2008; 78 Suppl 1:6-10.
Score: 0.229
-
The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008 Sep; 53(9):2307-12.
Score: 0.226
-
The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Jun; 27(12):1293-9.
Score: 0.221
-
Role of obesity in GORD-related disorders. Gut. 2008 Mar; 57(3):281-4.
Score: 0.220
-
Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review. Scand J Gastroenterol. 2008; 43(6):645-53.
Score: 0.217
-
The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007 Dec; 56(12):1654-64.
Score: 0.211
-
Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):696-701.
Score: 0.209
-
Temporal trends in new and recurrent oesophageal strictures in a Medicare population. Aliment Pharmacol Ther. 2007 May 15; 25(10):1223-9.
Score: 0.208
-
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007 Mar; 150(3):262-7, 267.e1.
Score: 0.205
-
Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):143-53.
Score: 0.203
-
Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):17-26.
Score: 0.202
-
Obesity increases oesophageal acid exposure. Gut. 2007 Jun; 56(6):749-55.
Score: 0.201
-
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 02; 143(3):199-211.
Score: 0.184
-
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
Score: 0.182
-
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8.
Score: 0.181
-
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005 Jan; 54(1):11-7.
Score: 0.177
-
Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9.
Score: 0.170
-
Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol. 2004 May; 99(5):806-12.
Score: 0.169
-
Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002 Aug; 37(8):899-904.
Score: 0.149
-
Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol. 2002 Jul; 97(7):1635-9.
Score: 0.148
-
Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology. 2001 Dec; 121(6):1294-9.
Score: 0.143
-
Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 07 29; 7(1):55.
Score: 0.139
-
Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001 Jul; 96(7):2013-8.
Score: 0.138
-
Corpus gastritis is protective against reflux oesophagitis. Gut. 1999 Aug; 45(2):181-5.
Score: 0.121
-
Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med. 1999 Mar-Jun; 72(2-3):81-92.
Score: 0.118
-
Opposing time trends of peptic ulcer and reflux disease. Gut. 1998 Sep; 43(3):327-33.
Score: 0.114
-
Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155.
Score: 0.112
-
Associations between different forms of gastro-oesophageal reflux disease. Gut. 1997 Nov; 41(5):594-9.
Score: 0.107
-
Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA. 2017 09 12; 318(10):939-946.
Score: 0.106
-
Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
Score: 0.101
-
Symptomatic reflux disease: the present, the past and the future. Gut. 2014 Jul; 63(7):1185-93.
Score: 0.083
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
Score: 0.080
-
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9.
Score: 0.077
-
Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288.
Score: 0.075
-
Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2009 Apr; 136(4):1155-7.
Score: 0.059
-
Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr. 2008 Aug; 47(2):141-6.
Score: 0.057
-
Prevalence and histological features of the gastric cardia-type mucosa in children. Dig Dis Sci. 2008 Jul; 53(7):1792-6.
Score: 0.055
-
Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
Score: 0.053
-
Anthropometric correlates of intragastric pressure. Scand J Gastroenterol. 2006 Aug; 41(8):887-91.
Score: 0.049
-
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May; 54(5):710-7.
Score: 0.045
-
Obesity and disease of the esophagus and colon. Gastroenterol Clin North Am. 2005 Mar; 34(1):63-82.
Score: 0.045
-
Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol. 2004 Nov; 2(11):978-84.
Score: 0.044
-
The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov; 99(11):2210-6.
Score: 0.044
-
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001 Apr; 96(4):979-83.
Score: 0.034
-
Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol. 1999 Dec; 94(12):3395-6.
Score: 0.031
-
Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2019 02; 64(2):367-372.
Score: 0.029
-
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998 May; 43(5):1001-8.
Score: 0.028
-
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
Score: 0.025
-
Weight Change and Weight Cycling Are?Not?Associated With Risk of Barrett's?Esophagus. Clin Gastroenterol Hepatol. 2016 12; 14(12):1839-1840.
Score: 0.024
-
Physical activity and the risk of Barrett's esophagus. Dis Esophagus. 2016 Apr; 29(3):248-54.
Score: 0.022
-
Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006 Mar; 130(3):639-49.
Score: 0.012